CAR-T Digest- August 2020 CAR-T Digest- August 2020 A total of 19 new trials registered for CAR-Ts in August 2020 in the US 74% of new trials registered were in Phase 1, 16% in Phase 1/2 Out of all trials […]
CAR-T Digest- August 2020 CAR-T Digest- August 2020 Tessa Therapeutics published data from two Phase 1/2 trials of CD30 CAR-T therapy in R/R Hodgkin lymphoma 06 Aug 2020 TT11 (Autologous CD30 CAR-T cell therapy) – Tessa Therapeutics Combined results from […]
CAR-T Digest- August 2020 CAR-T Digest- August 2020 Novartis announced that Kymriah has met primary endpoint in its pivotal Phase 2 ELARA study in follicular lymphoma 04 Aug 2020 Kymriah (Tisagenlecleucel; CD19 targeting autologous T cell immunotherapy) – Novartis Phase […]
